Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
N-acetylcysteine for Smoking Reduction
NCT00751257Phase 2Completed
- Sponsor
- Medical University of South Carolina
- Start
- Dec 2006
- Primary completion
- Oct 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of acetylcysteine in nicotine dependence, sponsored by Medical University of South Carolina. Primary endpoints: Carbon Monoxide Levels and Smoking Level. Started Dec 2006; status: completed.
02
Drugs
acetylcysteine
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT00751257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00751257.